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Stress urinary incontinence (SUI) and pelvic organ prolapse (POP) are major health issues that detrimentally impact the quality of
life of millions of women worldwide. Surgical repair is an effective and durable treatment for both conditions. Over the past two
decades there has been a trend to enforce or reinforce repairs with synthetic and biological materials. The determinants of surgical
outcome are many, encompassing the physical and mechanical properties of the material used, and individual immune responses,
as well surgical and constitutional factors. Of the current biomaterials in use none represents an ideal. Biomaterials that induce
limited inflammatory response followed by constructive remodelling appear to have more long term success than biomaterials that
induce chronic inflammation, fibrosis and encapsulation. In this review we draw upon published animal and human studies to
characterize the changes biomaterials undergo after implantation and the typical host responses, placing these in the context of
clinical outcomes.
1. Introduction
Stress urinary incontinence (SUI) and pelvic organ prolapse
(POP) are important health problems that cause a sizable
personal, societal, and economic burden [1]. SUI is defined
as the “involuntary leakage of urine on exertion, sneezing or
coughing” [2, 3]. POP is the “the descent of one or more of
the anterior vaginal wall, posterior vaginal wall, the uterus
(cervix), or the apex of the vagina (vaginal vault or cuff scar
after hysterectomy)” [4]. SUI and POP are thought to share a
common pathogenesis, weakening of the muscular and con-
nective tissues of the pelvic floor. Multiple etiological factors
have been implicated including ageing, obesity, pregnancy,
and childbirth, as well as genetic factors and menopause
[1, 5–7].
Following failure of conservative management including
physiotherapy, corrective surgery is considered to be themost
effective and durable treatment for both SUI and POP. Most
of the older surgical techniques relied upon suturing the local
tissues to the back of the pubic bone (colposuspension) or
using an autologous fascial sling. More recently there has
been a growing trend to reinforce repairs using both synthetic
and biological materials. This practice has been adapted
from hernia surgery where there is established evidence
that repairs reinforced with synthetic mesh provide superior
outcomes.
Syntheticmeshes were popularized in pelvic floor surgery
for SUI following the work of Ulmsten and Petros [8]. The
mid-urethral tape (MUT) involved a minimally invasive
approach to implant a thin synthetic mesh underneath the
mid-urethral point. Early reports of cure rates in the range
of 80–90% further propelled the uptake of this technology.
Following the early success of MUT and a randomized
control trial against colposuspension, synthetic mesh for SUI
was soon introduced [9]. This was not based on long term
supportive data but rather a grandfather clausewhich permit-
ted introduction of a new material based on its similarity to
an index product, which was used for hernia repair, namely,
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polypropylene mesh. A long term follow-up, the Ward and
Hilton [9] study, demonstrated a 4% exposure of mesh rate.
Subsequentlymeshwas introduced for the treatment of pelvic
organ prolapse (POP) and this has resulted in a significant
problem with mesh exposure which has led to enormous
medico-legal problems, particularly in the United States of
America.
The following decade has seen a rapid rise in reports
of mesh for POP related complications, but it is clearly
important to differentiate mesh exposure (erosion) used for
SUI from that used for POP. Thus reports of debilitating
complications of vaginal mesh implantation have emerged
including vaginal wall erosion (0–25.6%), chronic pain (0–
5.5%), and sexual problems (1.9–17%) [10]. Although it can
be debatedwhether these rates are high, the complications are
oftendifficult to treat, requiring further hospital visits, further
tests, and further reconstructive surgery.The situation has not
escaped the attention of medical regulatory bodies such as
the FDA who have issued statements warning patients and
surgeons of the potential dangers ofmesh use for POP [11, 12].
More recently there has been a wave of class action litigation
law suits raised against device manufacturers by patients who
have suffered mesh complications, such that several major
manufacturers have withdrawn products from the market.
Biological grafts are alternatives to synthetic mesh. The
most commonly used material, autologous fascia, has been
used for over 100 years in the treatment of SUI with good
efficacy. The main drawback however is the need to harvest
the graft from a donor site (fascia lata from the thigh or
rectus fascia from the abdominal wall) and potential morbi-
dity (e.g., wound infection, scar, nerve injury, and hernia)
[13]. There is a limitation on how much graft can be har-
vested which precludes its use in POP which is associated
with relatively large fascial defects. This can be avoided by
using grafts derived from cadavers or alternatively animal
derived collagen matrices (e.g., porcine dermis, porcine
small intestine, and bovine dermis). However, thesematerials
require extensive processing decellularization, sterilization,
and cross-linking processes to resist degradation [14]. While
this renders materials nonimmunogenic, it can impact their
biomechanical properties [15].There is also the risk of viral or
prion transmission [13]. Clinical studies are limited; however
clinical experience is that all of the materials appear to be
associated with graft failure in the medium term due to the
body’s response to the material, leading its encapsulation and
subsequent degradation with limited remodeling.
It is likely that biomaterials are subject to multifacto-
rial problems because of (1) their physical properties (e.g.,
porosity and degradability), (2) their mechanical properties
(e.g., stiffness and strength), or (3) the nature of the patient’s
immune response to the implanted biomaterials. In addition,
surgical and patient specific factors (e.g., individual anatomy
and comorbidities) are likely to play a role, though these are
not modifiable by material design.
To provide a simple context for this review we depict the
current hypotheses of how failures of implant might occur
through several routes in cartoon form in Figure 1 where
the implanted material is shown conceptually as a hammock
attached to two trees (the supporting structures of the pelvic
floor).
In the case of successful implantation, it is currently
thought that the material induces an acute inflammatory
response, which leads to constructive remodeling and mate-
rial integration (Figure 1(d)).
The aimof this review is to characterize these changes and
responses, from the available human and animal studies, and
relate them to clinical outcomes, thereby guiding the design
of novel materials for this challenging clinical application.
2. Methods
TheMEDLINE database was searched for articles describing
studies investigating the in vivo response to biomaterials used
routinely in pelvic floor surgery or that have been studied
in the context of clinical trials. The search was limited to
the years 1990 to 2013. The following search terms were
used: “pelvis,” “pelvic floor,” “vagina,” “in vivo,” “in vitro,”
“biocompatibility,” “prolapse,” “incontinence,” “biomaterial,”
“sling,” “mesh,” “polypropylene,” “autografts,” “allografts,” and
“xenografts.” Abstracts were screened for relevance by 2
reviewers before full articles were retrieved. Articles were
included if they described the changes in physical or biome-
chanical properties of materials after implantation in animals
or humans or the histological features of the host response to
the implanted material. Implantation sites were restricted to
subcutaneous, intravaginal, or abdominal muscles.
3. Results
In total 10 studies assessing autologous materials, 11 assessing
allograft materials, 24 assessing xenografts, and 24 assessing
polypropylenemeshes comparedwith other syntheticmeshes
were included. These studies are summarized in Tables 2, 3,
4, and 5.
3.1. Biological Materials
3.1.1. AutologousMaterials. Autologous grafts harvested from
the rectus fascia and fascia lata have long been used in
SUI surgery. A major advantage of autografts over synthetic
materials is that erosion is almost unheard of [16]. A possible
disadvantage to using autografts is that the connective tissues
of patients with SUI may be inherently weak predisposing
to failure. Nevertheless the overall long term outcomes with
autografts are largely excellent with reported rates of cure
generally over 90% [17, 18].
Biomechanical Properties of Autologous Materials. Four stud-
ies describing changes inmechanical properties of autologous
materials over a 12–16-week period were found. Uniaxial
stress strain testing of autologous rectus fascia before and
after implantation in rabbit vagina and anterior abdomi-
nal wall showed no significant decrease of ultimate tensile
strength (UTS) (the maximum stress a material can take
before failing) and Young’s modulus (YM) (material stiff-
ness), at twelve weeks after implantation [19, 20]. However,
there was a reduction in surface area of the grafts by 50%
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Material implantation Mechanical failure
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Material implantation Acute inﬂammatory
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Material implantation Acute inﬂammatory
response
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Erosion of native tissues
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Figure 1: Cartoon of how patients can respond to materials implanted in the pelvic floor: (a) mechanical failure, (b) material recognized as
non-self and isolated from body tissues with encapsulation, (c) exposure (erosion), and (d) optimal result for implanted material.
suggesting that significant degradation had occurred [19, 20].
A comparison ofmechanical strength of autologousmaterials
used for sling was carried out by Choe et al. [21]. They
harvested dermis, rectus fascia, and vaginal mucosa from
20 women undergoing vagina prolapse surgery and they
tested displacement and maximum load with the Instron
tensiometer.This study showed that fascia lata had the highest
mean maximum load to failure (217N), followed by human
dermis (122N), rectus fascia, and vaginal mucosa (both 42N)
in women undergoing surgeries for various reasons [21].
Autologous rectus fascia showed no significant decrease in
tear resistance using the trouser tear test after 4 months of
subcutaneous implantation in rodents [22]. In summary in
all four studies there was agreement that the mechanical
properties did not change significantly over a 12- to 16-week
duration [19–22].
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Host Response to Implanted Autologous Materials. Eight stud-
ies analysed the host response to autologous materials over a
time period up to 90 days [19, 20, 23–29]. In the majority of
studies, unless stated otherwise, biomaterials were assessed
after implantation by conventional blindly scored histol-
ogy (staining of fixed samples by haematoxylin and eosin
(H&E)), trichromes, and/or the presence of proangiogenic
cells.
Hilger and colleagues assessed human cadaveric skin and
autologous fascia after implantation in the abdominal and
vaginal walls of New Zealand white rabbits. Materials were
harvested at 6 and 12 weeks. Histological analysis demon-
strated that autologous fascia promoted a relatively minimal
inflammatory response and neovascularization but moderate
collagen infiltration when compared to fenestrated porcine
dermis and porcine collagen-coated polypropylene mesh
[20]. Jeong and coworkers described similar results noting
minimal inflammatory response and neovascularization in
rabbits when autologous fascia was implanted under the eye
lid for up to 8 weeks [24].
Two studies assessed histological changes in paravaginal
tissue after the implantation of autologous fascial slings for
SUI in women. In the study by FitzGerald et al. biopsies of the
sling were taken from 5 patients requiring revision surgery
due to persistent incontinence. The time since the initial
surgery ranged from 3 weeks to 4 years. The grafts explanted
after up to 8 weeks showed moderate uniform fibroblast
infiltration and neovascularization. Collagen remodelling
was evident in parts of the graft biopsied at 4 years, with
no evidence of chronic inflammation [23]. Woodruff and
colleagues performed a similar study in 24 patients under-
going sling revision for poor efficacy (2 patients), urinary
retention (9), and sling obstruction (13), 2–34 months after
implantation [27]. All grafts showed moderate uniform
fibroblast infiltration and moderate collagen fibers. All grafts
showed moderate degradation. There was no evidence of
encapsulation.
In summary these eight studies suggest that when autol-
ogous fascia is implanted there is a minimal to moderate
inflammatory response, a moderate degree of collagen pro-
duction, and a suggestion that grafts undergo a degree of
remodelling over the long term.
3.1.2. Allografts. Allografts used in pelvic floor reconstruc-
tion usually consist of fascia. The donors are screened for
infectious diseases before the grafts undergo cleaning, freeze
drying, and gamma irradiation to eradicate any infective or
immunogenic material. A concern with these grafts is that
they are often donated by the elderly who have an age related
weakening in connective tissues [30]; additionally processing
techniques such as freeze drying and solvent dehydration
may reduce the tensile strength [31]. Cadaveric grafts are
advantageous in that they avoid donor site complications.
In terms of efficacy, results are mixed. Some have shown
cadaveric fascia to demonstrate similar subjective cure rates
to autologous fascia at around 90% at 2 years [32]. However
others have shown that on urodynamic testing 42% of
cadaveric graft patients had SUI whereas no patients with
autologous grafts had SUI [33].
Biomechanical Properties of Allografts. Five studies investi-
gated the change in mechanical properties after implantation
of allografts in animals. All these studies utilized uniaxial
stress strain testing. The time after which samples were
explanted ranged from 60 days to 12 weeks [20, 22, 34–36].
After implanting human cadaveric dermis in rabbit vag-
ina, Hilger et al. reported a decrease in ultimate strength of
86.6% at 12 weeks; in comparison autologous fascia lost only
28.6% [20]. Conversely, Rice and colleagues found an increase
in tensile strength of cadaveric dermis (AlloDerm) from0.142
to 0.226MPa, increasing by about 80% of its initial strength,
60 days following subcutaneous implantation [36]. Walter
et al. reported that, after 12 weeks, following implantation
of cadaveric fascia lata in rabbit vagina, the tensile strength
decreased by approximately 90% [34]. Spiess et al. implanted
human cadaveric fascia lata subcutaneously on the abdom-
inal wall of 20 rats randomized into 2 survival groups at 6
and 12 weeks. They found no significant decrease in tensile
strength from 0.167 kg at week 6 and 0.185 kg at week 12 [35].
Kim et al., similarly, implanted human cadaveric fascia in 20
rats, randomized into 2 survival groups of 2 and 4 months.
They found no significant difference in fracture tough-
ness before implantation and after implantation in human
cadaveric fascia (from 2120 to 1145 J/m2, 𝑃 = 0.09) [22].
In summary, the available studies show disparate results
with respect to the changes in mechanical properties of
allografts following implantation. This may be attributable to
the heterogeneity in the type of allografts used, the animals
studied, the sites of implantation, and the assessment at
different time points.
Host Response to Implanted Allografts. In total eight studies
assessed the host response to allografts in both animals and
humans. The time since implantation ranged from 2 days up
to 65 weeks [20, 26, 27, 36–40].
Human cadaveric dermis and cadaveric fascia have been
found to be well integrated onto the abdominal wall [37, 40,
41] and rectus muscle [36, 38] in different animals, including
rats, rabbits, and pigs, as noted by moderate fibroblast
infiltration, new collagen production, and neovascularization
where materials were implanted from 2 days up to 62 weeks.
Human cadaveric dermis, after 12 weeks of implantation,
was similarly well integrated into vaginal tissues of rabbits.
However, it appeared highly fragmented suggesting signifi-
cant degradation [20]. Krambeck et al. also describe a faster
degradation of cadaveric fascia implanted subcutaneously
on the abdominal wall of rabbits with a fascial defect for
6 and 12 weeks compared to polypropylene or autologous
fascia [26]. VandeVord and colleagues also found moderate
cell infiltration and angiogenesis at 12 weeks following the
insertion of human cadaveric dermis and cadaveric fascia
slings under the bladder neck of rats; however there was a
moderate encapsulation after implantation [39]. Finally, in
the study byWoodruff et al. in 5 womenwho received human
cadaveric dermis grafts, biopsies 2–65months after implanta-
tion showed significant graft degradation with residual areas
of graft appearing acellular and encapsulated [27].
In summary, some studies suggest that allografts demon-
strate infiltration by host cells, new collagen production, and
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neovascularizationwhilst other studies suggest that a variable
degree of graft degradation occurs along with encapsulation
in the long term.There is a degree of agreement that allograft
induces an acute inflammatory response as inflammatory
infiltrates have been found populating the grafts.
3.1.3. Xenografts. A number of grafts from animals, mainly
porcine and bovine, have been used in pelvic floor surgery.
These materials undergo extensive processing after harve-
sting to decellularize them and render them non-immu-
nogenic. Additionally there are FDA regulations on animal
source and vaccination status which must comply with [42].
Porcine dermis may be artificially cross-linked using hexam-
ethylene diisocyanate to make it more resistant to enzymatic
digestion [43]. Clinical studies showed lower continence rates
for porcine dermis (approx. 80%) and increased reoperation
than that for synthetic tape or autologous fascia [44]. Porcine
small intestine submucosa (SIS) has shown cure rates from
79 to 93% at 2- and 4-year follow-up, respectively [45, 46].
However one study has raised concerns that SIS may not be
strictly acellular and may contain porcine DNA [47].
Biomechanical Properties of Xenografts. Nine studies investi-
gated themechanical properties of xenografts before and after
implantation. All these studies assessed either porcine dermal
collagen matrix, both cross-linked and non-cross-linked, or
porcine small intestine submucosa.
Hilger et al. assessed non-cross-linked porcine dermis
xenografts implanted on the abdominal wall and vaginal
wall of rabbits. After 12 weeks, half of the grafts implanted
in the vaginal wall were absent. The other half as well as
grafts implanted into the abdominal wall showed an average
reduction of 84.1% in ultimate strength [20]. Another study
assessed the long term mechanical integrity of cross-linked
porcine dermis. After 9 months following implantation in
the abdominal and vagina walls, grafts had degraded by 36%
and 46%, respectively. When subjected to mechanical testing
non-degraded graft fragments showed similar strength com-
pared to baseline values whilst degraded fragments decreased
by more than 50% [48].
Liu and colleagues implanted SIS and porcine dermal
collagen matrix in rats with surgically created abdominal
wall defects. The maximum load (at failure) at baseline for
SIS and dermal collagen matrix was 22.81N and 43.16N,
respectively. Following 12 weeks of implantation, there was
no significant change in the maximum load of cross-linked
porcine dermal collagen matrix and SIS [49]. Similarly other
workers observed an increase in the ultimate tensile strength
of SIS after 90 days of implantation from a baseline value
of 7.5 and 9.8N/cm2 at baseline, respectively, to 19.56 and
13.3N/cm. These results were averages of 48 implants in rats
[50]. Rice et al. also found an increase in tensile strength
of SIS after 60 days of implantation in a rat abdominal wall
defect from 0.142MPa at day 0 up to 0.226MPa after 60 days
of implantation [36]. Similarly, Zhang et al. implanted SIS
in abdominal wall of rats and they found increased strength
for SIS from 0.35MPa to 0.41 after 4 weeks [51]. Badylak
et al. repaired surgically created abdominal wall defects in
dogs with SIS (8 × 12 cm); they performed serial ball burst
strength tests after 1, 4, 7, and 10 days and then at 1, 3, 6,
and 24 months) [52]. There was an initial decrease in ball
burst strength from 73.37 pounds to 39.97 pounds by day
10. After day 10, the strength began to increase and after 2
years there was an increase to 157.20 pounds in burst stre-
ngth. Jenkins et al. showed an increase in strength in cross-
linked porcine matrices after 6 months of implantation in the
preperitoneal area from 0.07 ± 0.01N up to 22.36 ± 3.3N
[53]. In contrast, Ko and colleagues found no significant
difference in ultimate tensile strength of SIS after 4 months
of implantation in a porcine wall defect, with values ranging
from 41.3 to 74.8N/cm2 [54].
In summary it appears that non-cross-linked porcine
dermal collagen matrices are degraded rapidly (within 3
months) and lose most of their mechanical integrity within
this period. By contrast cross-linked porcine dermal collagen
matrix is more resistant to degradation and maintains its
mechanical properties for at least 3 months, whereas SIS
appears to increase in strength after as long as 2 years after
implantation.
Host Response to Implanted Xenografts. Twenty-four studies
assessing the host response to allografts were found. Non-
cross-linked porcine dermal collagen was assessed in four-
teen studies [20, 26, 27, 36, 39, 50–52, 54–61]. These studies
were performed on rats [36, 50, 51, 55, 58, 59], dogs [52, 55],
pigs [54, 57], and rabbits [26] in addition to few clinical
studies [20, 27, 39, 56]. Cross-linked porcine matrices were
assessed in seven studies [40, 49, 53, 62–66]. Animal models
mainly used were abdominal defects of rats [49, 62, 66],
rabbits [65], minipigs [53], pigs [40, 63], and primates [64].
Some of these studies looked at the acute response [39, 49, 53,
55, 59, 66]; some other studies looked at a more intermediate
response (1–3months) [20, 26, 36, 39, 40, 49–51, 54, 55, 57, 58,
60, 62–64, 66]; another looked at longer term response (more
than 3-months) [27, 40, 53, 62, 64, 65].
Hilger et al. and Pierce et al. found minimal neovascular-
ization and collagen ingrowth in porcine dermal xenografts
[20, 65]. Both studies agreed that the degradation of porcine
dermis is higherwhen the inflammatory response is high, and
it may accelerate this degradation process.They also reported
fragments encapsulated, which has been also found in many
studies with different species including rats [39, 62], rabbits
[65], pigs [40], primates [64], and humans [27].
In contrast, non-cross-linked SIS leads to high colla-
gen ingrowth with a moderate degree of remodeling and
orientation and high neovascularization [29, 36, 39, 49–
51, 54, 55, 57, 63]. On the other hand, many studies agree
with a very rapid degradation of the SIS which is replaced
by the host tissue [49, 51, 52, 55, 58, 66, 67]. Only two
studies reported an absence of host fibroblast infiltration and
fibrotic tissue penetration without neovascularization for SIS
implanted in rats [62] and rabbits [26]. In humans, Cole et al.
performed revision surgery on a patient who had developed
a bladder outlet obstruction after SIS implantation and found
that the implant had been encapsulated [60]. Neverthe-
less, other investigators, at 12 and 48 months, respectively,
found that the SIS was replaced by native tissue in humans
[56, 61].
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In summary, the available studies agree that the degree
of cross-linkage affects the rate of degradation and the
degree of the inflammatory response of the host. Studies on
cross-linked xenografts agree that cross-linked collagenous
matrices induce little cell infiltration; hence there is limited
collagen remodeling and graft degradation. In non-cross-
linked xenografts, cell infiltration was greater with faster
degradation rate and collagen production.
3.2. Polypropylene Mesh. There is a range of synthetic poly-
propylenemeshes that have been used.These are summarized
in Table 1 where they are classified as type 1, 2, 3, or 4 accord-
ing to their mesh size, where 1 is macroporous (>75𝜇m),
2 is less than 10 𝜇m, 3 is microporous with microporous
compartments, and 4 is nanoporous (<1𝜇m). Thus a wide
range of synthetic materials have been investigated for use in
the treatment of SUI.Thesematerials offer several advantages
including lack of transmission of infectious diseases and ease
of availability, as well as the sustainable tensile strength due
to their nondegradable nature [68].Meshmaterials have been
classified in to 4 groups based on the basis of porosity (micro-
porous or macroporous) and filamentous structure (monofil-
ament of multifilament) [69]. The initial clinical experi-
ence with mid-type II (microporous/multifilament fibers,
e.g., expanded PTFE) and III (macroporous and micro-
porous/multifilament fibers, e.g., Mersilene) meshes was
largely negative with excision rates of up to 30% for expanded
PTFE [70] and erosion rates of 17% for Mersilene (polyester)
[71].
A greater pore size is thought to be advantageous as it
allows the admittance of immune cells and greater collagen
ingrowth into the construct [13]. This is thought to reduce
the risk of mesh infection and accelerate and enhance host
tissue integration. Monofilament meshes are thought to
reduce the risk of infection in comparison to multifilament
meshes.The theoretical concernwith the latter is that bacteria
may colonize the 10 𝜇m subspaces between fibers which are
inaccessible for the larger host immune cells (9–20 𝜇m) [72].
Today a mid-type I polypropylene mesh that is macroporous
and monofilament is most commonly used [73] with cure
rates for SUI of >90% at 5 years.
Biomechanical Properties of Polypropylene. Seven studies
investigated the mechanical properties of polypropylene
meshes with implantation times ranging from two weeks in
animalmodels up to two years. Animalmodels usedwere rats
abdominal wall [35, 74], pig preperitoneal implantation [75],
rats rectus fascia [76], minipigs hernia repair [77], and ewes
abdominal and vaginal walls [78].
Melman et al. tested Bard Mesh, a knitted monofila-
ment mesh made of high molecular weight polypropylene
(HMWPP) and Ultrapro, a knitted macroporous compos-
ite mesh made of low molecular weight polypropylene
(LMWPP) and poliglecaprone (Table 1). They have been
implanted in minipigs hernia repair model for up to 5
months. HMWPP mesh decreased from maximal load at
failure 59.3N at 1 month to 36.0N at 5 months, while LWPP
mesh decreased from 61.5 to 37.8N at 5 months [77]. Long
term studies were carried out by Zorn et al. where TVT
and SPARC were compared to SIS in a rat abdominal wall
defect for up to 12 months. Both TVT and SPARC are
macroporousmeshesmade of polypropylenemonofilaments.
SPARC did not change its mechanical properties after 12
months of implantation (maximum load at baseline 0.453 kg
and at 12 months 0.497 kg). By contrast the maximum
load for TVT decreased from 0.779 kg to 0.523 kg for TVT
and for SIS decreased from 0.402 kg to 0.174 kg [74]. Also
Bazi et al. showed how similar are the mechanical proper-
ties of Gynecare TVT and Advantage, both macroporous
polypropylene monofilament meshes, compared with other
meshes such as IVS Tunneller, multifilament polypropylene
mesh, and SPARC. The lowest, at 25.2N, was TVT and the
highest, 34.9N, was Advantage, with no significance between
them after 24 weeks of implantation in rats rectus fascia
[76]. Also other studies agree on these parameters where
TVT was found to be able to comply with the highest break
load (0.740 kg), compared to 0.39 kg for fascia lata after
implantation in rats abdominal wall for up to 12 weeks [35],
andwas said to be less stiff than other syntheticmaterials used
formeshes (0.23N/mmcompared to nylon, 6.83N/mm) [79].
A recent study compared two sizes of meshes implanted
in two different places in a sheepmodel. Gynemeshwas cut in
two sizes (50 × 50mm and 35 × 35mm) and it was implanted
in 20 adult ewes, on the abdominal and vaginal walls for a
period of 60 and 90 days. Results showed that grafts of both
dimensions, implanted on the vaginal wall, were stiffer than
the ones implanted on the abdominal wall, after a period of
90 days [78].
However, they all agree that physical characteristics of
the mesh, such as monofilament or multifilament, porosity,
and polymer molecular weight, hugely affect the mechanical
performance of the implants in vivo.
Host Response to the Implanted Polypropylene. Twenty-one
papers have looked at the host response to the polypropylene
meshes. They have been assessed in various animal models:
rats abdominal wall [50, 58, 74, 80–82], rats rectus fascia
[38, 76, 83], rabbits bladder neck [84], rabbits abdominal
wall [85], rabbits rectus fascia [26], rabbits vaginas [65,
86], minipigs hernia [77], pigs peritoneum [75, 87], ewes
vagina [78, 88], and ewes abdominal wall [78] in addition to
few clinical studies [27, 89–91]. The studies have looked at
acute inflammatory responses to the most commonly used,
nondegradable meshes, described in Table 1. Few studies
looked at the acute inflammatory response that occurs from
the day of implantation up to 30 days [50, 58, 80–82, 85,
88]. Other studies looked at the immediate responses (1–3
months) [26, 75, 78, 83, 84, 86, 87] and longer term responses
(>3 months) where fibrosis and chronic inflammation can be
seen [27, 65, 74, 76, 77, 89–91].
A very recent study of Manodoro et al. showed how 30%
of Gynemesh grafts (50 × 50mm), implanted in ewes after
90 days, caused vaginal erosion and exposure. The study also
showed that 60% of the smaller Gynemesh meshes (35 ×
35mm) had a reduced surface (i.e., contracting) after 90 days
of implantation [78].
Falconer et al. reported a study on Prolene andMersilene
meshes. The biopsies were stained with Masson’s trichrome.
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Table 1: Classification of synthetic materials used in pelvic floor reconstruction.
Type Mesh pore size Structure Polymer Trade name Company
I Macroporous
>75 𝜇m
Monofilament Polypropylene
Uretex C. R. Bard
Gynecare TVT Ethicon, Johnson &Johnson
Bard Mesh Bard/Davol
SPARC American Medical Systems
In-Fast American Medical Systems
Monarc American Medical Systems
Lynx Boston Scientific
Advantage Boston Scientific
Obtryx Boston Scientific
Optilene B. Braun
Aris Mentor Corp
Perigee American Medical Systems
Parietene Covidien
Intepro American Medical Systems
Gynecare Prolift Ethicon, Johnson &Johnson
Surgipro Covidien
Prolene Ethicon, Johnson &Johnson
Prolene Soft Ethicon, Johnson &Johnson
Gynemesh PS Ethicon, Johnson &Johnson
Atrium AtriumMedical
Marlex C. R. Bard
Multifilament
Copolymer of
glycolide (90%)
and lactide (10%)
Vicryl Ethicon, Johnson &Johnson
Polypropylene and
polyglecaprone
Vypro Ethicon, Johnson &Johnson
UltraPro Ethicon, Johnson &Johnson
Polyglycolic acid Dexon Davis and Geck
II Macroporous
<10 𝜇m Multifilament
Expanded PTFF GORE-TEX W. L. Gore
Polyethylene
terephthalate Mersuture
Ethicon, Johnson &
Johnson
III
Macroporous with
microporous
components
<10 𝜇m
Multifilament
PTFE Teflon C. R. Bard
Polyethylene
terephthalate Mersilene
Ethicon, Johnson &
Johnson
Polypropylene IVS Tunneller Tyco Healthcare
Woven polyester Protegen Boston Scientific
IV Nanoporous
<1 𝜇m Multifilament
Silicon-coated
polyester Intermesh American Medical Systems
Dura mater
substitute
PRECLUDE
MVP Dura
substitute
W. L. Gore
Expanded PTFE,
pericardial
membrane
substitute
PRECLUDE
Pericardial
Membrane
W. L. Gore
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Table 2: Autologous fascia.
Author Sample Biomechanical properties Host response
FitzGerald et al.,
2000 [23]
Autologous rectus fascia
implanted in 5 patients suffering
from SUI. Samples obtained,
respectively, from transvaginal
revision after 3, 5, 8, and 17 weeks
and from replacement after 4
years.
(i) Moderate and uniform infiltration
of host fibroblasts and
neovascularization after 5 and 8 weeks
of implantation.
(ii) After 4 years of implantation, no
evidence of inflammatory cell infiltrate
or foreign body reaction and collagen
remodeling by connective tissue
organized longitudinally.
Jeong et al., 2000
[24]
Autologous lata fascia implanted
in 16 rabbits randomized into 4
survival groups and examined
after 1, 2, 4, and 8 weeks.
Implantation into upper eyelids.
(i) Low inflammatory cell infiltration.
(ii) Fibroblast infiltration and collagen
remodeling.
Choe et al., 2001 [21]
Dermis, rectus fascia, and
vaginal mucosa harvested from
20 women undergoing vagina
prolapse surgery.
Tensiometric analysis of full
strips versus patch suture slings.
Displacement and maximum
load calculated.
Kim et al., 2001 [22]
Autologous rectus fascia
implanted in 20 rats randomized
into 2 survival groups (2 and 4
months).
No significant decrease of the
fracture toughness calculated by
the trouser tear test over 4
months.
Dora et al., 2004 [19]
Autologous rectus fascia
implanted in 15 rabbits
randomized into 3 survival
groups (2, 6, and 12 weeks).
Implantation on the anterior
rectus fascia.
No significant decrease of
biomechanical properties after 12
weeks of implantation.
50% decrease in surface area.
Hilger et al., 2006
[20]
Autologous rectus fascia
implanted in 20 rabbits
randomized into 2 survival
groups (6 and 12 weeks). Half
implanted on the rectus fascia
and half on the posterior vagina
fascia.
No significant decrease of
biomechanical properties after 12
weeks of implantation.
(i) Collagen remodeling by moderate
collagen infiltration but encapsulation
as well.
(ii) Minimal inflammatory response.
(iii) Minimal neovascularization.
Krambeck et al.,
2006 [26]
Autologous rectus fascia
implanted subcutaneously on the
anterior rectus fascia of 10 rabbits
randomized into 2 survival
groups (6 and 12 weeks).
(i) Moderate fibrosis.
(ii) High degree of scarring.
(iii) High degree of inflammatory
infiltrate.
de Almeida et al.,
2007 [29]
Adult female rats incontinence
model. Marlex, autologous sling,
SIS, polypropylene mesh, and
sham at 30 and 60 days.
Reduced inflammatory response and
collagen production around
autologous grafts, in comparison with
synthetic materials and xenografts.
Woodruff et al.,
2008 [27]
Autologous fascia grafts
explanted after sling revision
from 5 women, due to different
complications, between 2 and 65
months after implantation.
(i) Moderate and uniform infiltration
of host fibroblasts and little
neovascularization.
(ii) Collagen remodeling by new
collagen fibers organized
longitudinally.
(iii) No evidence of encapsulation or
gross infection.
de Rezende Pinna et
al., 2011 [28]
Autologous fascia lata implanted
in 14 rabbits randomized into 2
survival groups (30 and 60 days).
Implantation into the right voice
muscle.
(i) No significant inflammatory
reaction.
(ii) No significant fibrosis or scarring.
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Table 3: Allografts.
Author Sample Biomechanical properties Host response
Sclafani et al., 2000
[37]
Human cadaveric dermis (AlloDerm)
disk implanted subdermally behind a
patient’s ear. Micronized human
cadaveric dermis (AlloDerm) injected
intradermally and subdermally in 2
different locations behind a patient’s
ear. Both implants were examined 3
months and 1 month after
implantation, respectively.
(i) Both materials extensively invaded by
host fibroblasts.
(ii) Both materials present new collagen
ingrowth.
Kim et al., 2001
[22]
Human cadaveric fascia implanted in
20 rats randomized into 2 survival
groups (2 and 4 months).
No significant decrease of
the fracture toughness
calculated by the trouser
tear test.
Walter et al., 2003
[34]
Freeze-dried and gamma-irradiated
human cadaveric lata fascia implanted
in 18 rabbits and excised 12 weeks after
implantation.
Significant decrease of
biomechanical properties
after 12 weeks of
implantation.
Spiess et al., 2004
[35]
Human cadaveric fascia lata implanted
subcutaneously on the abdominal wall
of 20 rats randomized into 2 survival
groups (6 and 12 weeks).
No significant decrease of
tensile strength with time.
Yildirim et al.,
2005 [38]
Human cadaveric lata fascia implanted
subcutaneously on the abdominal wall
in 20 rabbits randomized into 4
survival groups (2, 7, 15, and 30 days).
(i) Acute inflammation by high cell
infiltration predominantly of
polymorphous granulocytes.
(ii) Integration in host tissue by moderate
fibrotic process and muscle infiltration on
day 30, with persistent inflammatory
response.
Krambeck et al.,
2006 [26]
Cadaveric fascia lata implanted
subcutaneously on the anterior rectus
fascia of 10 rabbits randomized into 2
survival groups (6 and 12 weeks).
(i) Moderate to high focal fibrosis.
(ii) Minimal to moderate degree of scar.
(iii) High degree of inflammatory
infiltrate.
Hilger et al., 2006
[20]
Human cadaveric dermis and lata
fascia implanted in 20 rabbits
randomized into 2 survival groups (6
and 12 weeks). Half implanted on the
rectus fascia and half on the posterior
vagina fascia.
Very significant decrease of
biomechanical properties
after 12 weeks of
implantation.
(i) Two missing or fragmented materials
implanted on the vagina after 12 weeks.
(ii) Moderate inflammatory response.
(iii) Minimal neovascularization.
(iv) Minimal collagen ingrowth without
significant cell infiltration.
Woodruff et al.,
2008 [27]
Human cadaveric dermis slings
explanted after revision from 2
women, due to different complications,
between 2 and 65 months after
implantation.
(i) Moderate levels of encapsulation.
(ii) High levels of degradation.
(iii) Peripheries of the grafts invaded by
fibroblasts but central portions remained
acellular.
VandeVord et al.,
2010 [39]
Human cadaveric dermis and fascia
lata implanted in 16 rats, respectively,
and both randomized into 4 survival
groups (2, 4, 8, and 12 weeks).
Implantation around the bladder neck,
anchored to the surrounding tissues.
(i) Thin fibrous capsule formation.
(ii) Moderate cell infiltration and
angiogenesis.
Rice et al., 2010
[36]
Human cadaveric dermis (AlloDerm)
implanted in 18 rats randomized into 2
survival groups (30 and 60 days).
Subcutaneous implantation on
abdominis rectus muscle defect.
Increase of tensile strength
after 30 days and, again,
increase of tensile strength
after 60 days, respectively,
to 30 days.
(i) Moderate amounts of collagen
deposition well organized.
(ii) Abundant revascularization.
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Table 3: Continued.
Author Sample Biomechanical properties Host response
Kolb et al., 2012
[40]
Human cadaveric dermis (AlloDerm)
implanted subcutaneously in 5 pigs
randomized into 4 survival groups (7,
21, 90, and 180 days).
(i) Robust inflammatory response after 7
days of implantation, which achieved
maximal level at 21 days, with formation
of granulomas and areas of necrosis noted
within the graft.
(ii) Moderate fibroblast infiltration,
collagen ingrowth, and
neovascularisation.
(iii) Moderate levels of encapsulation.
Mersilene was found to induce a higher inflammatory
response compared to Prolene, which triggered a minimal
inflammatory reaction [89].
Pierce et al. reported a long term study comparing biolog-
ical and synthetic grafts implanted in rabbits. Polypropylene
caused a milder inflammatory reaction with more long term,
better host tissue incorporation compared to natural grafts
[65]. Also Bazi et al. evaluated biopsies on the basis of
inflammatory infiltrate, fibrosis, mast cell presence, muscular
infiltration, and collagen filling of the mesh on an arbitrary
scale described as low, moderate, or extensive based on H&E,
periodic acid-Schiff, and toluidine blue staining of tissue.
They agreed that all of thematerials (Advantage, IVS, SPARC,
and TVT) induced inflammation and collagen production,
with SPARC being the one with the mildest response and
TVT the one with the highest inflammatory response [76].
Elmer et al. reported an increase in macrophages and mast
cell counts and amild but persistent foreign body response to
polypropylenemeshes [91].This study is consistentwith other
reported investigations where the polypropylene meshes are
invaded with both macrophages and leukocytes, signs of
inflammation, resulting in collagen production [27, 38, 65, 76,
83, 85].
In summary the studies agree that polypropylene meshes
provoke a fairly pronounced inflammation, leading to a
massive cell infiltration into the scaffold and ultimately to
collagen production [27, 29, 48, 76, 83, 84, 86, 90–92].
4. Relating Postimplantation Changes to
Clinical Outcomes
4.1. Biomechanics. In general, when biological materials fail
this is due to enzymatic degradation after implantation,
leading to a loss of mechanical support and weakening of the
repair. This appears to apply particularly to the non-cross-
linked xenogenic matrices. Chemically cross-linking appears
to prevent this degradation and improve the mechanical
outcomes. Unfortunately there is a lack of clinical evidence
on how these mechanical outcomes translate into patient
outcomes. Autologous grafts are the most successful bio-
logical material used in contemporary practice and the
studies reviewed appear to support the long termmechanical
integrity of these grafts. Nevertheless, they present several
important limitations that are related to the need to harvest
from a donor site. However use of cadaveric tissues avoids
these limitations; however their quality depends on the
age and comorbidities of the donor and this is maybe the
reason for the mixed results in mechanical properties. This
is consistent with the available clinical studies which suggest
that allografts have poorer cure rates than autologous grafts.
We have found that polypropylene maintains its mor-
phology and strength after implantation for up to 24 weeks
[35, 74, 76]. However there was evidence that stiffness
increases [77, 93]. This is consistent with durable cure rates
particularly in SUI surgery (there is still some question
regarding efficacy of transvaginal POP repair, compared with
native tissue repair). The major issue with polypropylene
meshes is the associated serious complications, in particular
vaginal or urinary tract exposure (up to 10–14%). There
is some evidence that meshes with greater stiffness cause
the surrounding tissue to weaken, an effect termed stress
shielding [94]. This can be compared to the effect of metal
implants on the surrounding bone after orthopedic surgery.
This effect could lead to thinning of the surrounding vaginal
tissues as predisposing to erosion.
4.2. Host Response. Biomaterials implanted into the bodywill
always attract the attention of the immune system.With some
materials there is anM1macrophage response of constructive
remodeling; this appears to be the case with some biological
matrices, SIS in particular. With materials which the body
cannot remodel or integrate such as polypropylene meshes,
the macrophage response is much more aggressive, an M2
macrophage response [95, 96].
It appears that a state of constant inflammation can be
generated by some patients in response to some of these
nondegradable materials. Constant inflammation leads to
an upregulation of degradative enzymes; although these
enzymes cannot degrade the material, they may damage the
surrounding extracellular matrix and contribute to tissue
thinning and mesh exposure. Moreover perpetuation of the
inflammatory response can also result in activated fibroblasts,
which produce excessive collagen laid down in a disorganized
fashion around the implant (i.e., fibrosis), encapsulating the
material. A small amount of fibrosis is arguably advantageous
to the repair in SUI, providing a stable back stop allowing
urethral compression. However excessive fibrosis may lead to
mesh contraction resulting in increased pull on the adjacent
tissues leading to complications such as voiding dysfunction,
pain, and painful intercourse. In POP this excessive fibrotic
response can lead to mesh exposure which presents a major
reconstructive surgical challenge, often necessitating repeat
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Table 4: Xenografts.
Author Sample Biomechanical properties Host response
Badylak et al.,
2001 [52]
Abdominal wall defect repaired
with SIS in 40 dogs randomized
into 8 survival groups (1, 4, 7, and
10 days and 1, 3, 6, and 24
months).
Strength was decreased from
day 1 to day 10 after
implantation, followed by a
progressive increase, until
reaching double of the
original strength 24 months
after implantation.
Rapid degradation with associated and
subsequent host remodeling.
Badylak et al.,
2002 [55]
Abdominal wall defect repaired
with SIS in 10 dogs and 30 rats,
both randomized into 4 survival
groups (1 week, 1 month, 3
months, 6 months, and 2 years).
(i) No shrinkage or expansion of the graft site
over the 2-year period of the study.
(ii) One week after implantation, abundant
levels of polymorphonuclear leukocytes
diminished to negligible after 1 month.
(iii) Moderate neovascularization.
(iv) By 3 months, graft material was not
recognizable and was replaced by moderately
well-organized host tissues including
collagenous connective tissue, adipose tissue,
and skeletal muscle.
Cole et al., 2003
[60]
SIS removed from a 42-year-old
female patient 4 months after
pubovaginal implantation of the
sling due to severe obstruction.
(i) Completely intact acellular sling.
(ii) Well defined fibrous capsule.
(iii) Chronic inflammatory response.
Zhang et al., 2003
[51]
SIS implanted in the abdominal
wall of rats for up to 2 months.
SIS together with the
abdominal wall has increased
strength.
Levels of interleukin 2 and interleukin 6 were
high straight after the operation but they
become normal after 2 months.
Wiedemann and
Otto, 2004 [56]
Biopsies taken from the
implantation site of the SIS band
under the vaginal mucosa from 3
patients during reoperation, at a
mean of 12.7 months, after
pubourethral sling procedures
due to recurrent urinary stress
incontinence.
(i) Focal residues of SIS implant.
(ii) No evidence of a specific tissue reaction
that might point to a foreign body reaction.
(iii) No evidence of any significant
immunological reaction and in particular no
evidence of any chronic inflammatory reaction.
Konstantinovic et
al., 2005 [50]
Abdominal wall defect repaired
with SIS in 24 Wistar rats
randomized into 4 survival
groups (7, 14, 30, and 90 days).
Significant increase of
biomechanical properties after
90 days of implantation.
(i) Moderate acute inflammatory response at
day 7, decreased to minimal after 90 days.
(ii) Moderate neovascularization.
(iii) Abundant collagen deposition well
organized after 90 days.
Macleod et al.,
2005 [62]
SIS and cross-linked porcine
dermis (Permacol) implanted
subcutaneously on the anterior
rectus fascia of 18 rats each
randomized into 5 survival
groups (1, 2, 4, 10, and 20 weeks).
For both grafts:
(i) absent acute inflammatory response,
(ii) from moderate chronic inflammation after
1 week of implantation to minimal after 20
weeks,
(iii) absent eosinophilic infiltration and stromal
fibroblastic reaction over the entire
implantation,
(iv) from moderate fibrosis and vascularity
around the grafts after 1 week of implantation
to minimal after 20 weeks.
Poulose et al.,
2005 [57]
12 female pigs were implanted
with SIS intraperitoneally for up
to 6 weeks.
(i) Cell infiltration.
(ii) Vascularization.
(iii) Collagen deposition and remodelling.
Thiel et al., 2005
[58]
SIS implanted subcutaneously on
the abdominal wall of 30 rats
randomized into 3 survival
groups (7, 30, and 90 days).
(i) Moderate inflammatory reaction increased
to severe after 90 days.
(ii) 86% of the graft was replaced by new
collagen fibers.
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Table 4: Continued.
Author Sample Biomechanical properties Host response
Krambeck et al.,
2006 [26]
SIS and porcine dermis
implanted subcutaneously on the
anterior rectus fascia of 10 rabbits
randomized into 2 survival
groups (6 and 12 weeks).
(i) Porcine dermis presented moderate fibrosis
which was minimal for SIS.
(ii) Minimal degree of scar for both grafts and
high degree of inflammatory infiltrate.
Ko et al., 2006
[54]
Abdominal wall defect repaired
with 8-layer SIS in 20 domestic
pigs randomized into 2 survival
groups (1 and 4 months).
No significant changes of
biomechanical properties after
4 months of implantation.
(i) Dense fibrous connective tissue ingrowth.
(ii) Minimal to mild mononuclear
inflammatory cell infiltrate throughout the
connective tissue.
Hilger et al., 2006
[20]
Porcine dermis implanted in 20
rabbits randomized into 2
survival groups (6 and 12 weeks).
Half implanted on the rectus
fascia and half on the posterior
vagina fascia.
Very significant decrease of
biomechanical properties after
12 weeks of implantation.
(i) Two missing or fragmented materials 12
weeks after being implanted on the vagina.
(ii) Moderate to strong inflammatory response.
(iii) Minimal collagen ingrowth without
significant cell infiltration.
(iv) Minimal neovascularization.
Kim et al., 2007
[59]
SIS implanted in the
subcutaneous dorsum of 3 rats
sacrificed after 2 weeks.
(i) Prominent infiltration and ingrowth of host
cells.
(ii) Few macrophages infiltrated or
accumulated around the grafts.
Rauth et al., 2007
[63]
SIS implanted on the peritoneal
surface of the abdominal wall of
6 pigs sacrificed 8 weeks after
implantation.
(i) 80% of contraction from original surface
area.
(ii) Moderate neovascularization.
(iii) Densely populated by host cells with
moderate amounts of new disorganized
collagen deposition.
Woodruff et al.,
2008 [27]
Porcine dermis slings explanted
after revision from 4 women, due
to different complications,
between 2 and 65 months after
implantation.
(i) Severe encapsulation.
(ii) No degradation.
(iii) No fibroblasts infiltration and
neovascularization.
Sandor et al.,
2008 [64]
Abdominal wall defect repaired
with SIS and cross-linked porcine
dermis (Permacol) in 33 primates
randomized into 3 survival
groups (1, 3, and 6 months).
(i) Considerable contraction after 1 month for
both materials, but not significant change over
the next 5 months.
(ii) Better integration of both materials at late
stage by scar formation.
(iii) Inflammatory cells infiltration 3 months
after implantation for SIS associated with
formation of few blood vessels.
(iv) Acellular porcine dermis over the entire
course implantation with substantial
inflammation surrounding their perimeter.
(v) Partial resorption for both materials after 6
months.
Pierce et al., 2009
[65]
Cross-linked porcine dermis
implanted on the abdominal wall
and posterior vagina of 18 rabbits
sacrificed 9 months after
implantation.
11 grafts remained intact
without significant changes of
biomechanical properties
compared to the baseline
values. They were just thicker
and tolerated with less
elongation at failure. Seven
grafts were partially degraded
but thicker again and with
significant decrease of all
biomechanical properties.
(i) Host connective tissue incorporation
between fibers.
(ii) Intense foreign body reaction in degraded
grafts.
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Table 4: Continued.
Author Sample Biomechanical properties Host response
VandeVord et al.,
2010 [39]
SIS and porcine dermis
implanted in 16 rats, respectively,
and both randomized into 4
survival groups (2, 4, 8, and 12
weeks). Implantation around the
bladder neck, anchored to the
surrounding tissues.
(i) Thin fibrous capsule formation.
(ii) Moderate cell infiltration and angiogenesis
for SIS and minimal for porcine dermis.
Rice et al., 2010
[36]
Abdominal wall defect repair
with SIS (Surgisis) in 18 rats
randomized into 2 survival
groups (30 and 60 days).
Increase of tensile strength
after 30 days and, increase of
tensile strength after 60 days,
respectively, to 30 days.
(i) Moderate amounts of collagen deposition
well organized.
(ii) Abundant revascularization.
Deprest et al.,
2010 [61]
13 patients underwent secondary
sacrocolpopexy because of a graft
related complication after the
initial sacrocolpopexy with
porcine dermal collagen
(Pelvicol) (9) or SIS (Surgisis) (4).
(i) Pelvicol presented high degradation rates
associated with no foreign body reaction.
(ii) Pelvicol remnants were integrated into
collagen rich connective tissue with limited
neovascularization (scar host tissue).
(iii) No significant body foreign reaction to
Surgisis grafts.
(iv) Surgisis no longer recognizable replaced by
irregularly organized connective tissue and fat
tissue.
Liu et al., 2011
[49]
Abdominal wall defect repaired
with SIS and acellular porcine
dermal matrix in 50 Sprague
Dawley rats randomized into 5
survival groups (1, 2, 4, 8, and 12
weeks).
After initial decrease of
biomechanical properties at
week 2, these were increased
over the next 10 weeks
reaching similar values to
week 1.
(i) Pronounced inflammatory response 1 to 4
weeks after implantation for SIS compared with
porcine dermis, but falling to similar negligible
values for both after 12 weeks.
(ii) Large neovascularization and collagen
deposition, which was higher for SIS group.
(iii) SIS implants degraded more quickly and
were almost totally replaced by organized
collagenous tissues.
(iv) Contraction at the first weeks leading to
significant lower surface area in both materials.
Jenkins et al., 2011
[53]
Abdominal wall defect repaired
with porcine dermal matrix in 24
Yucatan minipigs randomized
into 2 survival groups (1 and 6
months).
Significantly greater
incorporation strengths after 6
months compared with 1
month.
(i) Moderate cell infiltration.
(ii) Moderate extracellular matrix deposition.
(iii) Moderate neovascularisation.
(iv) Partial degradation and from widely to
mild fibrous encapsulation.
Kolb et al., 2012
[40]
Cross-linked porcine dermis
(Permacol) implanted
subcutaneously in 5 pigs
randomized into 4 survival
groups (7, 21, 90, and 180 days).
(i) Mild inflammatory response decreased to
minimal from day 7 to day 180 after
implantation.
(ii) None to minimal neovascularization after
180 days.
(iii) Small amount of residual SIS remained
surrounded by mild to moderate chronic
inflammation.
(iv) Moderate levels of encapsulation.
Daly et al., 2012
[66]
Abdominal wall defect repaired
with porcine dermis in rats
randomized into 3 survival
groups (1, 3, and 35 days).
(i) Cell infiltrates into all grafts by day 35.
(ii) Degradation of the scaffold most
pronounced at the periphery with fibrous
tissue, angiogenesis, and foreign body giant
cells noted.
(iii) Grafts surrounded by a dense and
circumferentially organized connective tissue.
(iv) Mononuclear cells decreased in number
compared with earlier time points.
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Table 5: Polypropylene meshes.
Author Sample Biomechanical properties Host response
Falconer et al.,
2001 [89]
16 women were implanted with TVT for
up to 2 years: 6 with Mersilene and 10
with Prolene.
Mersilene induces higher inflammatory
response than Prolene. Mersilene is easier
to extract than Prolene.
Klinge et al.,
2002 [80]
Heavy weight monofilament with small
pore size (HWM) and low weight with
large pore size multifilament (LWM) on
the posterior abdominal wall of rats for
7, 14, 21, and 90 days.
(i) HWM: intense inflammation,
embedded in connective tissue.
(ii) LWM: less pronounced inflammatory
response and fibrotic capsule, with
collagen distributed within the mesh.
Wang et al.,
2004 [90]
17 women with sling erosion and 7
women with voiding difficulties
implanted with TVT and SPARC.
Pronounced fibrosis around the
fibers—erosion and voiding difficulty as a
result.
Rabah et al.,
2004 [84]
Implantation of Surgipro and cadaveric
fascia lata in rabbit’s bladder neck for 6
and 12 weeks.
(i) Cadaveric fascia lata group: the
implant was incorporated in a plate of
fibrous tissue.
(ii) Polypropylene mesh: inflammation
localized on the graft.
Spiess et al.,
2004 [35]
TVT and cadaveric fascia lata implanted
in abdominal wall of rats for 6 and 12
weeks.
TVT has the greater break
load and the maximum
average load compared to
cadaveric fascia lata.
Zheng et al.,
2004 [81]
Prolene and Pelvicol implanted in full
thickness abdominal wall defects in rats
for 7, 14, 30, and 90 days.
Prolene prosthesis shows the presence of
leukocytes in the activated state.
Konstantinovic
et al., 2005 [50]
Marlex and non-cross-linked Surgisis
implanted on the anterior abdominal
wall of rats for 7, 14, 30, and 90 days.
(i) Marlex: more pronounced
inflammatory reaction and
vascularization throughout the graft than
Surgisis
(ii) Surgisis: milder inflammatory
reaction.
Yildirim et al.,
2005 [38]
Gynecare TVT, SPARC, polypropylene
mesh, and IVS implanted in contact
with the rats rectus muscle for up to 30
days.
Inflammation and fibrosis are decreased
in large pore meshes.
Thiel et al., 2005
[58]
Monofilament polypropylene mesh,
silicone mesh, SIS, and PLA were
implanted subcutaneously on the
abdomen of rats for 7, 30, and 90 days.
Polypropylene induces the mildest
inflammatory response among the
samples.
Bogusiewicz et
al., 2006 [83]
Monofilament TVT and multifilament
IVS were implanted in rats rectus fascia
for 42 days.
(i) They induce production of similar
amount of collagen.
(ii) Differences in the arrangement of
collagen and inflammation intensity.
Boulanger et al.,
2006 [87]
Vicryl, Vypro, Prolene, Prolene Soft, and
Mersuture were implanted in pigs
peritoneum for 10 weeks.
(i) Vicryl: low level of inflammation and
completely absorbed.
(ii) Vypro: intense inflammation and
strong fibrotic response.
(iii) Prolene and Prolene Soft: well
integrated, weak inflammatory response.
(iv) Mersuture: no good integration.
Krambeck et al.,
2006 [26]
SPARC mesh, human cadaveric fascia,
porcine dermis, SIS, and autologous
fascia were implanted in rabbits rectus
fascia for 12 weeks.
(i) Polypropylene mesh has the greatest
scar formation.
(ii) Polypropylene has the mildest
inflammatory response.
Boukerrou et al.,
2007 [75]
Preperitoneal implantation of Vicryl,
Vypro, Prolene, Prolene Soft, and
Mersuture mesh for 2 months in pigs.
Nonabsorbable,
monofilamentous,
macroporous materials
(type I) seem more
resistant, retract less, and
have the best tolerance.
.
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Author Sample Biomechanical properties Host response
Spelzini et al.,
2007 [82]
Polypropylene type I mesh and
macroporous silk construct were
implanted in rat fascial defects for 7, 14,
30, and 90 days.
Polypropylene meshes induce a moderate
inflammatory response and not
architectural degradation.
Zorn et al., 2007
[74]
Rat abdominal wall was implanted with
SPARC, TVT, and SIS for 6 weeks and 9,
6, 9, and 12 months.
TVT has tensile
properties similar to
SPARC and they are
superior to Stratasis.
Bazi et al., 2007
[76]
Rats rectus fascia was implanted with
Advantage, IVS, SPARC, and TVT for
up to 24 weeks.
They all show similar
mechanical properties
after removal.
They induce different host responses due
to different porosity.
Tayrac et al.,
2007
Ewes vaginas were implanted with a
noncoated LW polypropylene mesh
(Soft Prolene) and a coated one
(Ugytex) from 1 to 12 weeks.
Similar inflammatory response between
the two materials.
Huffaker et al.,
2008 [86]
Rabbits vaginas were implanted with
Pelvitex (collagen-coated) and
Gynemesh (uncoated polypropylene
meshes) for up to 12 weeks.
Both materials induce a mild foreign
body reaction with minimal fibrosis.
Woodruff et al.,
2008 [27]
24 grafts were explanted in women
undergoing sling revision after 2–34
months. Grafts were polypropylene
meshes, autologous fascia, porcine
dermis, and cadaveric dermis.
No evidence of degradation or
encapsulation, abundant host infiltration.
Neovascularisation was visible.
Elmer et al.,
2009 [91]
Prolift was implanted in humans for 1
year.
(i) Increase in macrophages and mast
cells count.
(ii) Mild but persistent foreign body
response.
Pierce et al.,
2009 [65]
Polypropylene mesh versus cross-linked
porcine dermis implanted in rabbits
vagina and abdomen for 9 months.
Polypropylene caused milder
inflammatory reaction, more long term,
good host tissue incorporation.
Melman et al.,
2011 [77]
Bard mesh (HWPP), Ultrapro (LWPP),
and GORE INFINIT Mesh (ePTFE) in
minipigs hernia repair for 1, 3, and 5
months.
Their maximum tensile
strength decreases for all
of them.
(i) Inflammation decreases with time.
(ii) Cell infiltration increases with time.
Pascual et al.,
2012 [85]
Surgipro, Optilene, and GORE INFINIT
Mesh (ePTFE) were implanted in rabbits
abdominal wall defect for 14 days.
LWPP implants might be
improved by the newly
formed tissue around it.
(i) PTFE induces an increased
macrophage response when compared to
polypropylene.
(ii) Increase in collagen deposition in
high porosity meshes.
Manodoro et al.,
2013 [78]
Gynemesh in two sizes (50 × 50mm and
35 × 35mm) implanted in 20 adult ewes
for 60 and 90 days, both on the
abdominal and vaginal walls.
Implants were contracting
more when implanted on
the vaginal wall,
compared to abdominal
wall.
Grafts implanted on the
vaginal wall are stiffer
than the ones implanted
on the abdominal wall,
after retrieval.
(i) 30% of the 50 × 50meshes caused
vaginal erosion and exposure.
(ii) 60% of the 35 × 35meshes had
reduced surface (i.e., contracting after 90
days.)
HWPP: heavy weight polypropylene.
LWPP: lightweight polypropylene (also called soft); ePTFE: expanded polytetrafluoroethylene; PLGA: polylactide-co-glycolide acid; PLA: polylactide acid;
PGA: polyglycolide acid.
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procedures with no guarantee of symptom resolution. Never-
theless with the observation that the vast majority of patients
do well with mesh, it can be concluded that some degree of
fibrosis is helpful to the surgical management whereas clearly
excessive fibrosis is detrimental.
Implantation of autologous fascia in general showed good
integration within host tissues, associated with a low inflam-
matory response, compared to polypropylene meshes and
degree of graft remodelling in the available human studies
[50, 84]. It must be borne in mind that the human studies
were all reoperative cases for clinical failure. It is difficult to
speculate on whether all successful outcomes result in fully
integrated and remodelled graft.Non-cross-linked xenografts
are associated with clinical failure due to rapid degradation
which is presumably too soon for the regeneration of strong
tissues in its place [20, 24, 29]. The cross-linked grafts avoid
this but rather similar to the synthetic mesh are associated
with a perpetuated inflammatory response as the body is
unable to integrate and remodel them.This ultimately leads to
encapsulation of the graft. It would therefore seem appropri-
ate that there should be a proper balance of degradation and
replacement by new host tissue with xenografts. SIS appears
to fulfill this.
This relationship between grafts and host tissues will vary
for different materials and with different individuals. Here it
is worth noting that as many as 15% of the population are
allergic to nickel and more than 80% can become sensitized
to nickel on sustained exposure [97] and that there are very
successful studies involving muscle regeneration using decel-
lularized ECM [98]. Therefore, it is clear that the immune
response to any foreign material is complex, dynamic, and
patient specific. The fact that polypropylene meshes provoke
little adverse reaction when implanted in the abdominal wall
for hernia repair but are associated with complications in
the pelvic floor may also suggest a site-specific host response
notwithstanding the differences in biomechanical aspects
[99]. This contrasting response has been confirmed in ewes
[78], therefore the need for relevant animal models for longer
studies [100].
5. Perspective on the Ideal Material
Whilst authors have previously described paradigms of the
ideal material, we suggest that these have been unrealistic
[101]. Ultimately a permanent material will always cause
complications in some patients due to variation in individual
immune responses. Conversely degradable materials will fail
in some patients. The question is which is least desirable?
Whilst recurrent symptoms can always be treated by correc-
tive surgery, the complications of polypropylene mesh such
as chronic pain have proven resistant to treatment in many
cases. Thus we suggest that materials for this application
should be degradable based on the principle of least harm.
With this inmind, it is essential that the degradability is tuned
so that it allows enough time for the development of a neotis-
sue that is able to mechanically support the pelvic organs. A
material that does not cause any inflammation is unrealistic
and probably undesirable as an initial inflammatory response
is required to promote angiogenesis and collagen ingrowth,
integrating thematerial.This is essentially anM1macrophage
response. For this to happen, the material should be readily
permeable to host cells. On a practical level any material
for this application needs to be robust to withstand surgical
handling and provide support at the point of insertion. We
suggest that a more realistic material for this application
would be the one that
(i) is degradable,
(ii) provokes an acute inflammatory response,
(iii) undergoes tissue remodeling,
(iv) is permeable to cells,
(v) is mechanically robust at point of implantation.
6. Conclusion and Future Perspective
The clinical experience suggests that both synthetic and
biological materials can provide successful outcomes when
used in the surgical management of pelvic floor disorders.
However, it has become clear that there is an incidence
of significant complications of polypropylene meshes and
that many surgeons do not consider the complication rate
acceptable. Both the host response and the mechanical prop-
erties of the materials need to be taken into consideration
to predict success of the implants, in addition to their
response to dynamic loading.There has clearly been a lack of
adequate preclinical evaluationwith polypropylenemesh and
we suggest several stepswhichmaymake the development for
new materials an altogether safer endeavor:
(i) a better understanding of the forces within the
pelvic floor, whose materials need to cope with when
implanted;
(ii) computational modeling of how materials might per-
form under load for many years (this can be achieved
using in virtuomodels once established);
(iii) the investigation of immune responses in patients in
whommaterials perform well over many years versus
patients in whom they cause severe complications
(using biochemical markers, genomic markers, and
non-invasive imaging);
(iv) the development of better animalmodels that develop
the complications associated with vaginal mesh use
such as exposure;
(v) establishment of standardized criteria to evaluate the
performance of materials in in vivo and in vitro
studies so that they can be accurately compared.
There are several other factors which require urgent
attention but are beyond the scope of this review. Surgical
expertise based on training and experience in reconstructive
surgery is a key factor in outcomes of pelvic floor procedures
and there is a need to ensure that surgeons are adequately
trained. Patient specific issues, such as individual anatomy
and tissue strength, could also impact outcomes and further
investigation remains necessary to assess these aspects and
their role in determining outcome [102]. Although databases
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to track complication rates exist, such as MAUDE and
Postmarket Surveillance Studies, the medical community
needs to participate more fully in these databases in order to
more critically audit patient outcomes and move forward.
Ultimately to develop new effective and safe materials
there is a need for amultidisciplinary approach that combines
the efforts of those working in regenerative medicine, bioma-
terials, and surgery.
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